Home › Funds › Kalehua Capital Management LLC › PHVS
Kalehua Capital Management LLC position in PHVS
PHARVARIS N V · Health Care
Kalehua Capital Management LLC reported holding 198,772 shares of PHVS (PHARVARIS N V) in its Q2 2026 13F filing — a position valued at US$6.9M, representing 3.95% of its reported portfolio and ranking #9 among its reported holdings. Kalehua Capital Management LLC has disclosed PHVS holdings in 3 of the last 3 reported quarters, going back to Q4 2025.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Kalehua Capital Management LLC's PHVS position evolved
Kalehua Capital Management LLC first disclosed a stake in PHVS in Q4 2025 at 198,772 shares (US$5.5M). The position peaked in Q2 2026 at 198,772 shares, worth US$6.9M. Across 3 filings, Kalehua Capital Management LLC held the position steady without any share-count change. The most recent filing (Q2 2026) shows 198,772 shares valued at US$6.9M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2025 | 198.77K | $5.52M | New |
| Q1 2026 | 198.77K | $5.62M | Hold |
| Q2 2026 | 198.77K | $6.87M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About PHVS and 13F data
PHVS (PHARVARIS N V) is a Health Care company. 49 other funds we track also report a position in PHVS — the largest reported positions include GENERAL ATLANTIC, L.P. (US$226.5M), Foresite Capital Management IV, LLC (US$165.2M), venBio Partners LLC (US$160.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding PHVS
- GENERAL ATLANTIC, L.P. 6.55M sh · $226.53M · Q2 2026
- Foresite Capital Management IV, LLC 4.78M sh · $165.24M · Q2 2026
- venBio Partners LLC 4.64M sh · $160.57M · Q2 2026
- EQT Fund Management S.a r.l. 3.42M sh · $118.42M · Q2 2026
- DEERFIELD MANAGEMENT COMPANY, L.P. 3.38M sh · $116.74M · Q2 2026
- Bain Capital Life Sciences Investors, LLC 2.68M sh · $92.52M · Q2 2026
- Commodore Capital LP 1.43M sh · $49.28M · Q2 2026
- Novo Holdings A/S 1.40M sh · $48.41M · Q2 2026
- Saturn V Capital Management LP 1.31M sh · $45.44M · Q2 2026
- TCG Crossover Management, LLC 1.01M sh · $34.86M · Q2 2026
- Sofinnova Investments, Inc. 881.30K sh · $30.48M · Q2 2026
- 5AM Venture Management, LLC 797.60K sh · $27.58M · Q2 2026
More on Kalehua Capital Management LLC
FAQ
How long has Kalehua Capital Management LLC held PHVS?
Kalehua Capital Management LLC has disclosed PHVS holdings in 3 of the last 3 reported quarters, going back to Q4 2025.
What is Kalehua Capital Management LLC's current position in PHVS?
As of Q2 2026, Kalehua Capital Management LLC holds 198.77K shares of PHVS (PHARVARIS N V), valued at $6.87M, representing 3.95% of its reported portfolio and ranking #9.
Has Kalehua Capital Management LLC been buying or selling PHVS?
In the latest 13F filing (Q2 2026), Kalehua Capital Management LLC held unchanged its position in PHVS. The position peaked in Q2 2026 at 198.77K shares.
Which other funds hold PHVS?
Other major institutional holders of PHVS include GENERAL ATLANTIC, L.P., Foresite Capital Management IV, LLC, venBio Partners LLC, among 49 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.